EIF2AK3 and tauopathy: In recent years, there has been growing evidences that activation of the PERK (pancreatic endoplasmic reticulum kinase) pathway, a major branch of the UPR (unfolded protein response) involved in restoring protein homeostasis, may be a promising therapeutic target in the context of tauopathies [2–4].